Moreover, screening of compounds that enhance TFEB nuclei translocation via directly activating TFEB or antagonizing Rags–TFEB interaction could lead to additional therapeutic avenues for RagCS75Y cardiomyopathy. Here, EFNA5 is linked to cardiomyopathy.